Home / Inspections / 1169769

FDA Inspection 1169769 — Marlex Pharmaceuticals, Inc.

Marlex Pharmaceuticals, Inc. — FEI 1000121454

The FDA completed an inspection of Marlex Pharmaceuticals, Inc. on April 14, 2022 in New Castle, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 14, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Castle, DE (United States)

Facility

Other inspections at this facility

  • 1291594 (VAI Fri Nov 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1148584 (VAI Thu Aug 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1028879 (NAI Wed Sep 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 931349 (NAI Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 741052 (NAI Wed Aug 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources